Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
暂无分享,去创建一个
Dick J Veltman | Chris Vriend | H. Berendse | Y. D. van der Werf | D. Veltman | E. Foncke | O. A. van den Heuvel | J. Smit | K. van Dijk | C. Vriend | P. Raijmakers | Odile A van den Heuvel | Jan H Smit | Henk W Berendse | Elisabeth M J Foncke | Ysbrand D van der Werf | Pieter Raijmakers | Karin D van Dijk
[1] P. Rabins,et al. A comparison of nine scales to detect depression in Parkinson disease , 2012, Neurology.
[2] Jan Booij,et al. Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[3] S. Haber,et al. The cortico-basal ganglia integrative network: The role of the thalamus , 2009, Brain Research Bulletin.
[4] J. Price,et al. Neural circuits underlying the pathophysiology of mood disorders , 2012, Trends in Cognitive Sciences.
[5] Kuei Yuan Tseng,et al. Handbook of basal ganglia structure and function , 2010 .
[6] J. Kulisevsky,et al. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[7] H. Berendse,et al. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study , 2013, Neurobiology of Aging.
[8] W. Pirker,et al. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[9] A. Björklund,et al. Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts , 2012, Science Translational Medicine.
[10] I. Katz,et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[12] Johannes Schwarz,et al. Monoamine transporter availability in Parkinson’s disease patients with or without depression , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[13] H. Mayberg,et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.
[14] W. Poewe,et al. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[15] P. Boesiger,et al. Imbalance between Left and Right Dorsolateral Prefrontal Cortex in Major Depression Is Linked to Negative Emotional Judgment: An fMRI Study in Severe Major Depressive Disorder , 2008, Biological Psychiatry.
[16] Jeffrey L. Birk,et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. , 2009, The American journal of psychiatry.
[17] S. Leh,et al. Fronto-striatal connections in the human brain: A probabilistic diffusion tractography study , 2007, Neuroscience Letters.
[18] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[19] Oded Gonen,et al. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. , 2007, The American journal of psychiatry.
[20] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[21] D J Wyper,et al. Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.
[22] Irena Rektorova,et al. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[23] Nora Turjanski,et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.
[24] K. L. Leenders,et al. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Dag Aarsland,et al. Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.
[26] H. Groenewegen,et al. The Ventral Striatum as an Interface Between the Limbic and Motor Systems , 2007, CNS Spectrums.
[27] H. Groenewegen,et al. Organization of Prefrontal-Striatal Connections , 2010 .
[28] C. Hawkes. The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? , 2008, Movement disorders : official journal of the Movement Disorder Society.
[29] E. Bézard,et al. Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats , 2008, Neuroscience.
[30] R. Bressan,et al. Higher dopamine transporter density in Parkinson’s disease patients with depression , 2010, Psychopharmacology.
[31] V. Haroutunian,et al. The neuropathological basis for depression in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[32] Z. Illés,et al. Morphometric changes of gray matter in Parkinson's disease with depression: A voxel‐based morphometry study , 2008, Movement disorders : official journal of the Movement Disorder Society.
[33] L. Reneman,et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.
[34] J. Weiss,et al. Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. , 2011, The international journal of neuropsychopharmacology.
[35] M Filippi,et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease , 2010, Neurology.
[36] Gal Yadid,et al. VTA Dopamine Neuron Bursting is Altered in an Animal Model of Depression and Corrected by Desipramine , 2008, Journal of Molecular Neuroscience.
[37] P. Pollak,et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease , 1999, Journal of the Neurological Sciences.
[38] Gerty J. L. M. Lensvelt-Mulders,et al. Brain volume abnormalities in major depressive disorder: A meta‐analysis of magnetic resonance imaging studies , 2009, Human brain mapping.
[39] H. Rickards,et al. Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.